Predicting distant dissemination in patients with early breast cancer

By Arriagada Rodrigo   Rutqvist Lars-erik   Johansson Hemming   Kramar Andrew   Rotstein Sam  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1113-1121

Informa Healthcare

Access to resources Recommend Favorite

Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

By Gatineau M.  

Targeted Oncology, Vol. 1, Iss. 3, 2006-07 ,pp. : 114-122

Springer Publishing Company

Access to resources Recommend Favorite

Lymphatic relapse in women with early breast cancer: a difficult management problem

By McKinna F.   Gothard L.   Ashley S.   Ebbs S.R.   Yarnold J.R.  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1065-1069

Elsevier

Access to resources Recommend Favorite

Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients

By Welt Anja   Tewes Mitra   Aktas Bahriye   Hoffmann Oliver   Wiesweg Marcel   Ting Saskia   Reis Henning   Worm Karl   Richly Heike   Hense Jörg   Palmer Michael   Lee Benjamin   Wendling Johanna   Kossow Josef   Scheulen Max   Lehnerdt Cathrin   Kohl Marzena   Derks Cordula   Skottky Silke   Haus Ulrike   Schmid Kurt   Kimmig Rainer   Schuler Martin   Kasper Stefan  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 81-88

Springer Publishing Company

Access to resources Recommend Favorite

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

By Wang Fenghua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 331-335

Humana Press, Inc

Access to resources Recommend Favorite